SEI Investments’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $78.5M | Sell |
3,258,876
-17,966
| -0.5% | -$470K | 0.07% | 307 |
|
|
2026
Q1 | $92M | Sell |
3,276,842
-231,515
| -7% | -$6.16M | 0.08% | 246 |
|
|
2025
Q4 | $87.4M | Buy |
3,508,357
+618,265
| +21% | +$15.6M | 0.09% | 242 |
|
|
2025
Q3 | $73.6M | Buy |
2,890,092
+254,401
| +10% | +$6.28M | 0.08% | 248 |
|
|
2025
Q2 | $63.9M | Buy |
2,635,691
+425,156
| +19% | +$9.92M | 0.07% | 284 |
|
|
2025
Q1 | $56M | Buy |
2,210,535
+380,724
| +21% | +$9.96M | 0.07% | 307 |
|
|
2024
Q4 | $48.5M | Buy |
1,829,811
+94,124
| +5% | +$2.55M | 0.06% | 324 |
|
|
2024
Q3 | $50.2M | Buy |
1,735,687
+445,116
| +34% | +$13M | 0.07% | 321 |
|
|
2024
Q2 | $36.1M | Sell |
1,290,571
-370,153
| -22% | -$10.2M | 0.05% | 381 |
|
|
2024
Q1 | $46.1M | Buy |
1,660,724
+126,473
| +8% | +$3.51M | 0.07% | 315 |
|
|
2023
Q4 | $44.2M | Sell |
1,534,251
-11,787
| -0.8% | -$356K | 0.07% | 303 |
|
|
2023
Q3 | $51.3M | Sell |
1,546,038
-65,634
| -4% | -$2.32M | 0.09% | 215 |
|
|
2023
Q2 | $59.1M | Sell |
1,611,672
-37,096
| -2% | -$1.44M | 0.1% | 189 |
|
|
2023
Q1 | $67.3M | Buy |
1,648,768
+612,029
| +59% | +$26.4M | 0.13% | 155 |
|
|
2022
Q4 | $53.1M | Sell |
1,036,739
-336,933
| -25% | -$16.2M | 0.12% | 177 |
|
|
2022
Q3 | $60.1M | Buy |
1,373,672
+11,768
| +0.9% | +$572K | 0.13% | 136 |
|
|
2022
Q2 | $71.5M | Buy |
1,361,904
+395,783
| +41% | +$20.2M | 0.15% | 116 |
|
|
2022
Q1 | $50M | Sell |
966,121
-181,644
| -16% | -$9.42M | 0.1% | 197 |
|
|
2021
Q4 | $67.8M | Buy |
1,147,765
+35,958
| +3% | +$1.78M | 0.13% | 161 |
|
|
2021
Q3 | $47.8M | Buy |
1,111,807
+13,820
| +1% | +$612K | 0.1% | 212 |
|
|
2021
Q2 | $43M | Buy |
1,097,987
+303,155
| +38% | +$11.8M | 0.1% | 209 |
|
|
2021
Q1 | $29.1M | Sell |
794,832
-30,349
| -4% | -$1.08M | 0.07% | 276 |
|
|
2020
Q4 | $30.4M | Sell |
825,181
-550,764
| -40% | -$20.2M | 0.08% | 250 |
|
|
2020
Q3 | $47.9M | Sell |
1,375,945
-123,695
| -8% | -$4.34M | 0.14% | 126 |
|
|
2020
Q2 | $46.5M | Sell |
1,499,640
-81,744
| -5% | -$2.78M | 0.14% | 120 |
|
|
2020
Q1 | $49M | Sell |
1,581,384
-141,830
| -8% | -$4.83M | 0.18% | 93 |
|
|
2019
Q4 | $64M | Sell |
1,723,214
-53,477
| -3% | -$1.9M | 0.19% | 89 |
|
|
2019
Q3 | $60.6M | Buy |
1,776,691
+4,187
| +0.2% | +$152K | 0.16% | 113 |
|
|
2019
Q2 | $73M | Buy |
1,772,504
+35,439
| +2% | +$1.41M | 0.24% | 66 |
|
|
2019
Q1 | $70.1M | Sell |
1,737,065
-87,562
| -5% | -$3.51M | 0.24% | 72 |
|
|
2018
Q4 | $76.1M | Buy |
1,824,627
+322,281
| +21% | +$13.4M | 0.27% | 60 |
|
|
2018
Q3 | $62.9M | Sell |
1,502,346
-930,723
| -38% | -$35.8M | 0.23% | 69 |
|
|
2018
Q2 | $83.8M | Sell |
2,433,069
-245,783
| -9% | -$8.4M | 0.28% | 57 |
|
|
2018
Q1 | $90.2M | Buy |
2,678,852
+30,700
| +1% | +$1.06M | 0.35% | 48 |
|
|
2017
Q4 | $91M | Buy |
2,648,152
+406,917
| +18% | +$13.9M | 0.32% | 57 |
|
|
2017
Q3 | $75.9M | Buy |
2,241,235
+349,604
| +18% | +$11.2M | 0.27% | 66 |
|
|
2017
Q2 | $60.3M | Sell |
1,891,631
-125,896
| -6% | -$3.97M | 0.24% | 78 |
|
|
2017
Q1 | $65.5M | Sell |
2,017,527
-245,161
| -11% | -$7.73M | 0.29% | 62 |
|
|
2016
Q4 | $69.7M | Buy |
2,262,688
+78,672
| +4% | +$2.4M | 0.34% | 52 |
|
|
2016
Q3 | $70.2M | Sell |
2,184,016
-32,152
| -1% | -$1.08M | 0.36% | 48 |
|
|
2016
Q2 | $74M | Sell |
2,216,168
-244,662
| -10% | -$7.81M | 0.44% | 30 |
|
|
2016
Q1 | $69.2M | Buy |
2,460,830
+13,144
| +0.5% | +$375K | 0.43% | 33 |
|
|
2015
Q4 | $75M | Buy |
2,447,686
+958,399
| +64% | +$30.2M | 0.46% | 31 |
|
|
2015
Q3 | $44.4M | Buy |
1,489,287
+364,104
| +32% | +$11.7M | 0.41% | 41 |
|
|
2015
Q2 | $35.8M | Sell |
1,125,183
-284,461
| -20% | -$9.27M | 0.32% | 75 |
|
|
2015
Q1 | $46.5M | Buy |
1,409,644
+84,322
| +6% | +$2.68M | 0.4% | 46 |
|
|
2014
Q4 | $39.2M | Buy |
+1,325,322
| New | +$38M | 0.35% | 63 |
|
Other funds holding PFE
SEI Investments's PFE Position: Q2 2026 in Review
SEI Investments reduced its Pfizer (PFE) stake by 0.55% in Q2 2026, selling an estimated $470K and leaving 3,258,876 shares worth $78.5M. The position accounts for 0.07% of the portfolio, ranked #307.
SEI Investments first reported a position in PFE in Q4 2014 and has held it in 47 quarters since. The position peaked at $92M in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- SEI Investments held 3,258,876 shares of Pfizer worth $78.5M as of Q2 2026.
- SEI Investments sold 17,966 Pfizer shares in Q2 2026, an estimated $470K.
- Pfizer made up 0.07% of SEI Investments's portfolio in Q2 2026, its #307 holding.
- SEI Investments first reported a position in Pfizer in Q4 2014 and has held it in 47 quarters since.
- SEI Investments's Pfizer position peaked at $92M in Q1 2026.
- 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.